Loading...
Mixed Asset Passive

KBSTAR Healthcare Fixed Income Balanced (253290)

Update : 2022.12.05

NAV

10,781KRW

+0.53상승 (-%)

Market Price per share (KRW)

10,800KRW

-40하락 (-0.37%)

※ t-1 last price

trading volume

930shares

AUM

KRW 12.9billion

KBSTAR Healthcare Fixed Income Balanced (253290)

KEY POINT

Balanced ETF with both the stability of bonds and the profitability of stocks

KEY POINT

Seek to achieve stable yield of bonds and the profitability of the healthcare sector

Basic information

Download trading information

Update : 2022.12.05
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB KBSTAR HealthCare FixedIncome Balanced ETF
(253290)
FnGuide HealthCare Mix Index 2016.09.23 200,000 12,936,735,718
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 10,800
※ t-1 last price
10,780 930
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency
Year 0.35% (Designated participating company : 0.03%, Collective investment : 0.28%, trust : 0.02%, General affairs : 0.02%) Based on the business day before the interest payment date of the stocks constituting the index in June and December (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, NH Investment & Securities, Meritz Securities, Samsung Securities KB Securities, NH Investment & Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB KBSTAR HealthCare FixedIncome Balanced ETF

(253290)
FnGuide HealthCare Mix Index
Inception date Creation Unit
2016.09.23 200,000
AUM(0.1 billion) (KRW) Trustee
12,936,735,718 하나은행
Market Price per share (KRW) iNAV per share (KRW)
10,800
※ t-1 last price
10,780
Trading Volume (shares)
930
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.35% (Designated participating company : 0.03%, Collective investment : 0.28%, trust : 0.02%, General affairs : 0.02%)
Distribution Frequency
Based on the business day before the interest payment date of the stocks constituting the index in June and December (occasional payment)
Authorized Participants
KB Securities, NH Investment & Securities, Meritz Securities, Samsung Securities
Liquidity Providers
KB Securities, NH Investment & Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Balanced Index is an index consisting of stock items constituting the FnGuide Healthcare Index and three KTBs constituting the MKF 3-year KTB Index. It maintains a 7:3 ratio of bonds to stocks everyday.

View detailed index information

TOP 10 Holdings

Update : 2022-12-05
Rank , Name, proportion table
Rank Name Weight (%)
1 KTB01875-2412(21-10) 26.38
2 KTB03125-2506(22-4) 19.39
3 KTB02375-2703(22-1) 14.76
4 KBSTAR HealthCare 10.30
5 F 202212 9.88
6 원화예금 9.33
7 SAMSUNG BIOLOGICS 2.38
8 Celltrion 2.32
9 Celltrion Healthcare 2.23
10 HLB 1.43

proportion by sectors

Update : 2022.12.05
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 53.83
2 46.17

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2019-06-07 2019-06-11 50
2019-12-07 2019-12-11 34
2020-06-09 2020-06-11 10
2021-06-09 2021-06-11 10
2021-12-09 2021-12-13 11
2022-06-09 2022-06-13 16
2022-12-08 2022-12-12 91

Performance

performance

excel download

Update : 2022-12-05

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)
Since
inception
NAV 1.49 -1.73 -3.11 -9.20 7.30 -9.68 8.19
Benchmark Index 1.59 -1.59 -2.87 -8.79 8.47 -9.23 11.03
Outperformance -0.11 -0.14 -0.24 -0.42 -1.18 -0.45 -2.84

daily Performance

excel download

date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2022.12.02 10,800 -0.369하락 10,826.13 0.340상승
2022.12.01 10,840 0.416상승 10,789.44 0.135상승
2022.11.30 10,795 0.139상승 10,774.83 0.364상승
2022.11.29 10,780 0.512상승 10,735.66 -0.636하락
2022.11.28 10,725 -0.832하락 10,804.47 0.005상승
2022.11.25 10,815 -0.046하락 10,834.31 0.564상승
2022.11.24 10,820 0.417상승 10,773.47 0.079상승
2022.11.23 10,775 - 10,764.89 -0.131하락
2022.11.22 10,775 -0.139하락 10,779.02 -0.718하락
2022.11.21 10,790 -0.644하락 10,857.08 0.005상승
2022.11.18 10,860 -0.137하락 10,867.45 -0.123하락
2022.11.17 10,875 -0.229하락 10,880.87 -0.772하락
2022.11.16 10,900 -0.183하락 10,965.63 1.002상승
2022.11.15 10,920 0.877상승 10,856.74 -0.170하락
2022.11.14 10,825 -0.276하락 10,875.26 0.005상승
2022.11.11 10,855 1.023상승 10,739.96 0.106상승
2022.11.10 10,745 0.093상승 10,728.54 0.150상승
2022.11.09 10,735 0.186상승 10,712.38 0.622상승
2022.11.08 10,715 0.657상승 10,646.14 0.214상승
2022.11.07 10,645 0.188상승 10,623.3 0.006상승

Holdings

Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares
/ Par value
Weight(%) Market price (KRW)
1 KTB01875-2412(21-10) KR103501GBC2 583,333,333 26.38 568,869,583
2 KTB03125-2506(22-4) KR103501GC66 416,666,667 19.39 418,131,667
3 KTB02375-2703(22-1) KR103501GC33 333,333,333 14.76 318,254,333
4 KBSTAR HealthCare KR7253280002 21,141 10.3 222,086,205
5 F 202212 KR4165SC0002 2.05 9.88 212,954,000
6 원화예금 KRD010010001 201,248,628 9.33 201,248,628
7 SAMSUNG BIOLOGICS KR7207940008 59 2.38 51,330,000
8 Celltrion KR7068270008 287 2.32 49,938,000
9 Celltrion Healthcare KR7091990002 751 2.23 48,139,100
10 HLB KR7028300002 968 1.43 30,830,800
11 Yuhan KR7000100008 475 1.28 27,692,500
12 SKBP KR7326030004 254 0.85 18,415,000
13 HanmiPharm KR7128940004 68 0.8 17,306,000
14 SKBS KR7302440003 198 0.75 16,196,400
15 SD Biosensor KR7137310009 335 0.5 10,720,000
16 Celltrionph KR7068760008 162 0.49 10,594,800
17 SEEGENE KR7096530001 339 0.45 9,797,100
18 Hugel KR7145020004 80 0.42 8,968,000
19 ST Pharm KR7237690003 93 0.33 7,058,700
20 BIONEER KR7064550007 207 0.32 6,810,300
21 GC Corp KR7006280002 51 0.3 6,528,000
22 Hanmi Science KR7008930000 210 0.3 6,573,000
23 DAEWOONG PHARM KR7069620003 42 0.29 6,216,000
24 SCD KR7000250001 126 0.28 6,142,500
25 ILDONG PHARM KR7249420001 151 0.26 5,647,400
26 DENTIUM KR7145720009 61 0.25 5,422,900
27 MedyTox KR7086900008 46 0.25 5,382,000
28 HK inno.N KR7195940002 135 0.24 5,265,000
29 CHA Biotech KR7085660009 371 0.24 5,194,000
30 HUMASIS KR7205470008 297 0.23 4,930,200
31 BukwangPharm KR7003000007 577 0.22 4,644,850
32 HANALL BIOPHARMA KR7009420001 329 0.22 4,671,800
33 Lutronic KR7085370005 193 0.19 4,004,750
34 GC CELL KR7144510005 74 0.17 3,566,800
35 PharmaResearch KR7214450009 56 0.17 3,724,000
36 Jeisys Medical KR7287410005 463 0.17 3,713,260
37 GCH Corp KR7005250006 202 0.16 3,464,300
38 CLASSYS KR7214150005 161 0.15 3,131,450
39 Amicogen KR7092040005 151 0.14 3,125,700
40 Binex KR7053030003 261 0.14 2,988,450
41 YUNGJIN PHARM KR7003520004 838 0.12 2,622,940
42 JWPHARMA KR7001060003 119 0.11 2,338,350
43 IlyangPharm KR7007570005 126 0.11 2,299,500
44 VATECH KR7043150002 65 0.1 2,109,250
45 KUP KR7033270000 84 0.09 1,982,400
46 DIO KR7039840004 86 0.08 1,681,300
47 Boditech KR7206640005 166 0.08 1,693,200
48 DongwhaPharm KR7000020008 160 0.07 1,484,800
49 REYON KR7102460003 67 0.06 1,336,650
50 UBCARE KR7032620007 224 0.05 1,135,680
51 KOREA PHARMA KR7032300006 31 0.03 722,300
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.